399 related articles for article (PubMed ID: 32948180)
1. Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer's disease.
Wu Q; Chen Y; Gu Y; Fang S; Li W; Wang Q; Fang J; Cai C
BMC Complement Med Ther; 2020 Sep; 20(1):282. PubMed ID: 32948180
[TBL] [Abstract][Full Text] [Related]
2. Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San.
Fu X; Liu Q; Sun X; Chang H; Liu Y; Han J
J Alzheimers Dis; 2022; 85(1):7-19. PubMed ID: 34776439
[TBL] [Abstract][Full Text] [Related]
3. A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases.
Luo Y; Wang Q; Zhang Y
J Ethnopharmacol; 2016 Feb; 178():66-81. PubMed ID: 26680587
[TBL] [Abstract][Full Text] [Related]
4. Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis.
Bi Y; Han X; Lai Y; Fu Y; Li K; Zhang W; Wang Q; Jiang X; Zhou Y; Liang H; Fan H
J Ethnopharmacol; 2021 Oct; 278():114278. PubMed ID: 34087397
[TBL] [Abstract][Full Text] [Related]
5. Danggui Shaoyao San: comprehensive modulation of the microbiota-gut-brain axis for attenuating Alzheimer's disease-related pathology.
He J; Jin Y; He C; Li Z; Yu W; Zhou J; Luo R; Chen Q; Wu Y; Wang S; Song Z; Cheng S
Front Pharmacol; 2023; 14():1338804. PubMed ID: 38283834
[No Abstract] [Full Text] [Related]
6. Danggui-Shaoyao San alleviates cognitive impairment via enhancing HIF-1α/EPO axis in vascular dementia rats.
Ningning Y; Ying X; Xiang L; Yue S; Zhongda W; Ruoyu J; Hanwen S; Weiwei T; Yafeng Z; Junjie M; Xiaolan C
J Ethnopharmacol; 2024 Sep; 331():118306. PubMed ID: 38723920
[TBL] [Abstract][Full Text] [Related]
7. A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer's Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice.
Cheng XR; Cui XL; Zheng Y; Zhang GR; Li P; Huang H; Zhao YY; Bo XC; Wang SQ; Zhou WX; Zhang YX
Curr Alzheimer Res; 2015; 12(9):870-85. PubMed ID: 26159197
[TBL] [Abstract][Full Text] [Related]
8. In-depth transcriptomic analyses of LncRNA and mRNA expression in the hippocampus of APP/PS1 mice by Danggui-Shaoyao-San.
Song Z; Li F; He C; Yu J; Li P; Li Z; Yang M; Cheng S
Aging (Albany NY); 2020 Nov; 12(23):23945-23959. PubMed ID: 33221745
[TBL] [Abstract][Full Text] [Related]
9. Acute toxicology on Danio rerio embryo and adult from Chinese traditional medicine preparation Danggui Shaoyao san.
Luo R; He C; He J; Li Z; Wang Y; Hou M; Li P; Yu W; Cheng S; Song Z
J Ethnopharmacol; 2024 Mar; 321():117528. PubMed ID: 38043754
[TBL] [Abstract][Full Text] [Related]
10. The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease.
Cai H; Luo Y; Yan X; Ding P; Huang Y; Fang S; Zhang R; Chen Y; Guo Z; Fang J; Wang Q; Xu J
Sci Rep; 2018 Feb; 8(1):3104. PubMed ID: 29449587
[TBL] [Abstract][Full Text] [Related]
11. Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease.
Yang J; Li C; Liu Y; Han Y; Zhao H; Luo S; Zhao C; Jiang N; Yang M; Sun L
Front Pharmacol; 2022; 13():832299. PubMed ID: 36059953
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the mechanism of Danggui-Shaoyao-San in regulating the metabolome of nephrotic syndrome based on urinary metabonomics and bioinformatics approaches.
Wang Y; Fan S; Yang M; Shi G; Hu S; Yin D; Zhang Y; Xu F
J Ethnopharmacol; 2020 Oct; 261():113020. PubMed ID: 32592886
[TBL] [Abstract][Full Text] [Related]
13. The effects of Danggui-Shaoyao-San on neuronal degeneration and amyloidosis in mouse and its molecular mechanism for the treatment of Alzheimer's disease.
Yang C; Mo YS; Chen HF; Huang YH; Li SL; Wang H; Huang SQ; Chang X; Du Q; Wang Q
J Integr Neurosci; 2021 Jun; 20(2):255-264. PubMed ID: 34258924
[TBL] [Abstract][Full Text] [Related]
14. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
[TBL] [Abstract][Full Text] [Related]
15. Extract of Danggui-Shaoyao-San ameliorates cognition deficits by regulating DHA metabolism in APP/PS1 mice.
Huang J; Wang X; Xie L; Wu M; Zhao W; Zhang Y; Wang Q; Yao L; Li W
J Ethnopharmacol; 2020 May; 253():112673. PubMed ID: 32084555
[TBL] [Abstract][Full Text] [Related]
16. Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease.
Chen Y; Song X; Luo Y; Li G; Luo Y; Wang Z; He R; Lu J; Xiong G; Cheng H; Li H; Yang S
Evid Based Complement Alternat Med; 2023; 2023():9208017. PubMed ID: 36636607
[TBL] [Abstract][Full Text] [Related]
17. Intestinal flora study reveals the mechanism of Danggui Shaoyao San and its decomposed recipes to improve cognitive dysfunction in the rat model of Alzheimer's disease.
Jin Y; Liang S; Qiu J; Jin J; Zhou Y; Huang Y; He C; Yu W; Deng S; Cheng S; Song Z
Front Cell Infect Microbiol; 2023; 13():1323674. PubMed ID: 38076462
[TBL] [Abstract][Full Text] [Related]
18. Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer's disease through a network pharmacology approach.
Qu YJ; Zhen RR; Zhang LM; Gu C; Chen L; Peng X; Hu B; An HM
BMC Complement Med Ther; 2020 May; 20(1):157. PubMed ID: 32450873
[TBL] [Abstract][Full Text] [Related]
19. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's disease.
Zeng Q; Li L; Siu W; Jin Y; Cao M; Li W; Chen J; Cong W; Ma M; Chen K; Wu Z
Biomed Pharmacother; 2019 Dec; 120():109370. PubMed ID: 31563815
[TBL] [Abstract][Full Text] [Related]
20. Systems pharmacology-based mechanism exploration of Acanthopanax senticosusin for Alzheimer's disease using UPLC-Q-TOF-MS, network analysis, and experimental validation.
Zhuo Y; Fu X; Jiang Q; Lai Y; Gu Y; Fang S; Chen H; Liu C; Pan H; Wu Q; Fang J
Eur J Pharmacol; 2023 Sep; 954():175895. PubMed ID: 37422122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
